Yao-Wen Cheng
Hospitalist · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Yao-Wen Cheng’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A154478 · Current
Licensed to practise in California · since 2018 · expires 2027-11-30 · Ohio State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Year by year
| 2023 | 13 | 18 | 71 | 1.40 | $11,644 | $2,396 |
| 2022 | 47 | 51 | 75 | 3.02 | $30,791 | $7,499 |
| 2021 | 62 | 62 | 77 | 3.09 | $40,680 | $10,409 |
| 2020 | 45 | 46 | 73 | 3.63 | $29,128 | $7,784 |
| 2019 | 124 | 412 | 70 | 3.80 | $177,485 | $40,392 |
| 2018 | 147 | 381 | 69 | 2.39 | $164,200 | $38,249 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,067 | $177 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,326 | $110 |
2021: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,672 | $176 |
2020: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,059 | $184 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $28,523 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,369 | $179 |
| Hospital discharge day management, more than 30 minutes | 49 | $4,872 | $96 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $25,614 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,978 | $176 |
| Hospital discharge day management, more than 30 minutes | 44 | $4,343 | $97 |
Medicaid work
$670 in 2021
Medicaid paid $670 for 18 billed services this clinician did in 2021, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 18 | $670 |
| 2021 | 18 | 1 | 16 | $670 |
| 2019 | 75 | 1 | 18 | $2,753 |
| 2018 | 101 | 1 | 16 | $5,362 |
See the largest Medicaid services in earlier years
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 75 | $2,753 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 101 | $5,362 |
Drugs they prescribed that Part D paid
$33,157
Pharmacies billed $33,157 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 729) in 2024. At or below the middle of the specialty; the typical hospitalist clinician is at 4%.
693 generic and 36 brand-name prescriptions · $33,157 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gavilyte-C | 520 | $11,806 | $23 |
| Mesalamine | 21 | $2,775 | $132 |
| Budesonide Dr | 12 | $821 | $68 |
| Omeprazole | 54 | $656 | $12 |
| Peg-3350 and Electrolytes | 11 | $305 | $28 |
See all 7 drugs
| Gavilyte-C | 520 | $11,806 | $23 |
| Mesalamine | 21 | $2,775 | $132 |
| Budesonide Dr | 12 | $821 | $68 |
| Omeprazole | 54 | $656 | $12 |
| Peg-3350 and Electrolytes | 11 | $305 | $28 |
| Famotidine | 21 | $234 | $11 |
| Pantoprazole | 15 | $163 | $11 |
Year by year
| 2024 | 729 | 595 | 0% (0) | 5% | $33,157 |
| 2023 | 647 | 511 | 0% (0) | 10% | $44,745 |
| 2022 | 196 | 142 | 0% (0) | 13% | $15,675 |
| 2021 | 30 | 21 | 0% (0) | None | $3,690 |
| 2020 | 11 | None | 0% (0) | None | $11,080 |
| 2019 | 299 | 58 | 8% (25) | None | $41,083 |
| 2018 | 324 | 55 | 8% (26) | None | $34,466 |
| 2017 | 402 | 50 | 6% (24) | 21% | $26,754 |
| 2016 | 375 | 47 | 10% (38) | None | $32,491 |
| 2015 | 111 | 21 | 13% (14) | 15% | $5,043 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Gavilyte-C | 430 | $9,220 | $21 |
| Lialda | 14 | $3,059 | $219 |
| Budesonide Dr | 16 | $1,295 | $81 |
| Peg-3350 and Electrolytes | 23 | $607 | $26 |
| Omeprazole | 34 | $398 | $12 |
| Pantoprazole | 16 | $161 | $10 |
| Gabapentin | 13 | $96 | $7 |
2022: 2 drugs
| Gavilyte-C | 89 | $1,727 | $19 |
| Omeprazole | 22 | $256 | $12 |
2019: 6 drugs
| Humalog | 12 | $3,450 | $288 |
| Lactulose | 13 | $1,477 | $114 |
| Calcitriol | 12 | $391 | $33 |
| Pantoprazole | 15 | $136 | $9 |
| Furosemide | 27 | $102 | $4 |
| Spironolactone | 11 | $24 | $2 |
2018: 8 drugs
| Gabapentin | 15 | $1,015 | $68 |
| Ventolin Hfa | 12 | $986 | $82 |
| Hydrocodone-Acetaminophen | 12 | $365 | $30 |
| Atorvastatin | 11 | $293 | $27 |
| Fluconazole | 13 | $174 | $13 |
| Triamterene-Hydrochlorothiazid | 12 | $114 | $9 |
| Furosemide | 13 | $63 | $5 |
| Pantoprazole | 13 | $57 | $4 |
2017: 13 drugs
| Gabapentin | 27 | $838 | $31 |
| Proair Hfa | 12 | $718 | $60 |
| Ventolin Hfa | 12 | $699 | $58 |
| Hydrocodone-Acetaminophen | 14 | $468 | $33 |
| Ultra-Fine Mini Pen Needle | 11 | $462 | $42 |
| Atorvastatin | 18 | $384 | $21 |
| Levothyroxine | 13 | $289 | $22 |
| Warfarin | 13 | $165 | $13 |
| Pantoprazole | 11 | $162 | $15 |
| Amlodipine Besylate | 23 | $122 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $113 | $10 |
| Lisinopril | 11 | $111 | $10 |
| Furosemide | 11 | $96 | $9 |
2016: 8 drugs
| Anoro Ellipta | 11 | $3,464 | $315 |
| Gabapentin | 29 | $775 | $27 |
| Atorvastatin | 22 | $709 | $32 |
| Omeprazole | 16 | $540 | $34 |
| Hydrocodone-Acetaminophen | 17 | $497 | $29 |
| Topiramate | 11 | $120 | $11 |
| Amlodipine Besylate | 17 | $104 | $6 |
| Furosemide | 17 | $92 | $5 |
2015: 1 drug
| Atorvastatin | 12 | $228 | $19 |
Money from drug and device companies
$36 in 2021
| 2021 | 1 | 1 | None | $36 |
| 2020 | 1 | 1 | None | $99 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Endoflip | $36 | 1 payment
|
See the published payment
| Medtronic | Meals · 2021-09-23 | Endoflip | $36 |
See earlier years (2020)
2020: $99
| Janssen Biotech | Tremfya | $99 | 1 payment
|
Professional record
- NPI
- 1508246968
- Licence
- CA A154478California A154478: Current · expires 2027-11-30
- Trained
- Ohio State University College of Medicine, 2015
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Internal medicine (207R00000X); Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 710 Lawrence Expy Dept 248, Santa Clara, CA, 95051
- NPI first listed
- 2015-06-01
- NPI last updated
- 2022-05-12
- NPI record certified
- 2022-05-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2450 Ashby Ave Ste 5505, Berkeley, CA, 94705 · 350 Hawthorne Ave Rm 2308, Oakland, CA, 94609
This office lists an electronic records connection.